NSB 2.56% 4.0¢ neuroscientific biopharmaceuticals ltd

Ann: Investor Update Webinar, page-39

  1. 412 Posts.
    lightbulb Created with Sketch. 113
    I tried to catch the knife today at 0.09. The shares are in free fall.

    why would HREC approve an early phase trial in humans but not a phase 1? Perhaps they want to complete the early phase trial first? Perhaps they don’t want to approve a trial for 88 volunteers for phase 1?

    I think this may be a slight over reaction once details are clarified. This could be a minor amendment or it could be a catastrophe

    the biggest disgrace is managements handling of the situation.
 
watchlist Created with Sketch. Add NSB (ASX) to my watchlist
(20min delay)
Last
4.0¢
Change
0.001(2.56%)
Mkt cap ! $5.784M
Open High Low Value Volume
3.9¢ 4.0¢ 3.6¢ $5.263K 142.7K

Buyers (Bids)

No. Vol. Price($)
2 20181 3.6¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 125000 1
View Market Depth
Last trade - 15.40pm 28/06/2024 (20 minute delay) ?
NSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.